An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates
{{output}}
Aptamers serve as unique targeting ligands, making aptamer-drug conjugates (ApDCs) an attractive strategy for targeted cancer therapy. This study performs a comprehensive evaluation from rodents to non-human primates (NHP) of a protein tyrosine kinase 7 (PTK7)... ...
